WTO Opens with Note of ‘Cautious Optimism’ on Prospects for Agreement over Fisheries Subsidies and COVID Vaccine IP Waiver 12/06/2022 Elaine Ruth Fletcher The World Trade Organization’s Director General Dr Ngozi Okonjo Iweala said she was “cautiously optimistic” about the potential for WTO members to reach long-delayed agreements on issues such as a limited IP waiver for COVID vaccines as well as a decision to curb harmful fisheries subsidies that allow big industrial rigs to plunder the oceans […] Continue reading -> One In Three People Globally Need Assistive Technologies; ‘Stunning Disparity’ In Access 16/05/2022 Aishwarya Tendolkar From wheelchairs to memory aids, over 2.5 billion people in the world today need at least one assistive device either for communication, vision, mobility, as well as for certain cognitive functions, like memory aids. And the number is set to rise to 3.5 billion people by 2050 due to an ageing population and the prevalence […] Continue reading -> WTO Chief Hopes for “Workable Compromise” on TRIPS Waiver by June; US Signs Deal to Share COVID Vaccine Know-How with WHO 12/05/2022 Raisa Santos & Elaine Ruth Fletcher The United States National Institute of Health (NIH) has finalized an agreement with WHO’s COVID-19 patent sharing facility (C-TAP) to share the patent rights on 11 government-funded coronavirus medicine and vaccine technologies – in what is perhaps the most significant agreement to date with WHO to share closely-guarded pharma know-how. The announcement was made today […] Continue reading -> Moderna Seeks Dismissal in US Court of COVID-19 Vaccine Patent Infringement Lawsuit By Arbutus, Genevant 11/05/2022 Aishwarya Tendolkar Moderna has filed a brief in the United States District Court for the District of Delaware seeking the dismissal of a patent infringement lawsuit that pertains to the production and sale of its COVID-19 mRNA vaccine Spikevax. The lawsuit against the U.S-based pharmaceutical giant was filed by Arbutus Biopharma Corporation and Genevant Sciences, which had […] Continue reading -> After Months of Deadlock, WTO’s TRIPS Council Will Finally Discuss Intellectual Property Waiver Compromise 03/05/2022 Kerry Cullinan In a significant breakthrough, the World Trade Organization’s (WTO) TRIPS Council on Friday will finally discuss a compromise proposal on a waiver of intellectual property (IP) rights on COVID-19 vaccines – almost 18 months after it was first proposed by India and South Africa. Members attending an informal meeting of the TRIPS Council on Tuesday […] Continue reading -> Data-Sharing in the Time of COVID – Could Researchers Agree to Use a Common Clinical Trial ‘Repository’? 15/04/2022 Elaine Ruth Fletcher Nathalie Strub-Wourgaft, a senior scientist at the Drugs for Neglected Disease Initiative (DNDi) has a vision that could be critical to halting the next pandemic – but is esoteric, difficult to organize and even more challenging to build the trust and buy-in needed to make it really work. The vision is of a common clinical-trial […] Continue reading -> WTO IP Waiver ‘Compromise’ on COVID-19 Vaccines ‘Deeply Concerning’: Civil Society to European Leaders 30/03/2022 Aishwarya Tendolkar A compromise proposal on a World Trade Organisation’s (WTO) waiver on intellectual property for the production of COVID-19 vaccines is ‘problematic’, ‘largely insufficient’, and WTO members should not be politically pressured into adopting the text, several dozen civil society organisations said in an open letter published today. The letter, addressed to European Commissioners, European members […] Continue reading -> WTO Head Welcomes Compromise on IP Waiver for COVID Vaccines – But Activists and Pharma Express Dismay 16/03/2022 Kerry Cullinan The World Trade Organization’s (WTO) Director-Genera, Dr Ngozi Okonjo-Iweala has “warmly welcomed” the breakthrough reached this week over a waiver on intellectual property for the production of COVID-19 vaccines. “This is a major step forward and this compromise is the result of many long and difficult hours of negotiations. But we are not there yet. […] Continue reading -> South African President Lays Down Gauntlet to Europe: Approve IP Waiver And Procure Vaccines from African Manufacturers 18/02/2022 Elaine Ruth Fletcher South African President Cyril Ramaphosa Friday called on Gavi, The Vaccine Alliance, and COVAX, the global COVID vaccine consortium to begin procuring African-made versions of vaccines for COVID and other diseases, as soon as a network of new African manufacturing facilities, now in the making, are in full production. He spoke in Brussels at an […] Continue reading -> BioNTech To Ship Modular mRNA Vaccine Facilities in Containers to African Countries to Jump-start Production 16/02/2022 Elaine Ruth Fletcher The German-based BioNTech, which co-developed with Pfizer an mRNA COVID vaccine, said on Wednesday that it will set up modular “turnkey” mRNA vaccine facilities to produce the vaccine in Rwanda and Senegal in 2022 – with a fill-and-finish collaboration in Ghana as well. South Africa, which is the new hub for the WHO-supported mRNA vaccine […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
One In Three People Globally Need Assistive Technologies; ‘Stunning Disparity’ In Access 16/05/2022 Aishwarya Tendolkar From wheelchairs to memory aids, over 2.5 billion people in the world today need at least one assistive device either for communication, vision, mobility, as well as for certain cognitive functions, like memory aids. And the number is set to rise to 3.5 billion people by 2050 due to an ageing population and the prevalence […] Continue reading -> WTO Chief Hopes for “Workable Compromise” on TRIPS Waiver by June; US Signs Deal to Share COVID Vaccine Know-How with WHO 12/05/2022 Raisa Santos & Elaine Ruth Fletcher The United States National Institute of Health (NIH) has finalized an agreement with WHO’s COVID-19 patent sharing facility (C-TAP) to share the patent rights on 11 government-funded coronavirus medicine and vaccine technologies – in what is perhaps the most significant agreement to date with WHO to share closely-guarded pharma know-how. The announcement was made today […] Continue reading -> Moderna Seeks Dismissal in US Court of COVID-19 Vaccine Patent Infringement Lawsuit By Arbutus, Genevant 11/05/2022 Aishwarya Tendolkar Moderna has filed a brief in the United States District Court for the District of Delaware seeking the dismissal of a patent infringement lawsuit that pertains to the production and sale of its COVID-19 mRNA vaccine Spikevax. The lawsuit against the U.S-based pharmaceutical giant was filed by Arbutus Biopharma Corporation and Genevant Sciences, which had […] Continue reading -> After Months of Deadlock, WTO’s TRIPS Council Will Finally Discuss Intellectual Property Waiver Compromise 03/05/2022 Kerry Cullinan In a significant breakthrough, the World Trade Organization’s (WTO) TRIPS Council on Friday will finally discuss a compromise proposal on a waiver of intellectual property (IP) rights on COVID-19 vaccines – almost 18 months after it was first proposed by India and South Africa. Members attending an informal meeting of the TRIPS Council on Tuesday […] Continue reading -> Data-Sharing in the Time of COVID – Could Researchers Agree to Use a Common Clinical Trial ‘Repository’? 15/04/2022 Elaine Ruth Fletcher Nathalie Strub-Wourgaft, a senior scientist at the Drugs for Neglected Disease Initiative (DNDi) has a vision that could be critical to halting the next pandemic – but is esoteric, difficult to organize and even more challenging to build the trust and buy-in needed to make it really work. The vision is of a common clinical-trial […] Continue reading -> WTO IP Waiver ‘Compromise’ on COVID-19 Vaccines ‘Deeply Concerning’: Civil Society to European Leaders 30/03/2022 Aishwarya Tendolkar A compromise proposal on a World Trade Organisation’s (WTO) waiver on intellectual property for the production of COVID-19 vaccines is ‘problematic’, ‘largely insufficient’, and WTO members should not be politically pressured into adopting the text, several dozen civil society organisations said in an open letter published today. The letter, addressed to European Commissioners, European members […] Continue reading -> WTO Head Welcomes Compromise on IP Waiver for COVID Vaccines – But Activists and Pharma Express Dismay 16/03/2022 Kerry Cullinan The World Trade Organization’s (WTO) Director-Genera, Dr Ngozi Okonjo-Iweala has “warmly welcomed” the breakthrough reached this week over a waiver on intellectual property for the production of COVID-19 vaccines. “This is a major step forward and this compromise is the result of many long and difficult hours of negotiations. But we are not there yet. […] Continue reading -> South African President Lays Down Gauntlet to Europe: Approve IP Waiver And Procure Vaccines from African Manufacturers 18/02/2022 Elaine Ruth Fletcher South African President Cyril Ramaphosa Friday called on Gavi, The Vaccine Alliance, and COVAX, the global COVID vaccine consortium to begin procuring African-made versions of vaccines for COVID and other diseases, as soon as a network of new African manufacturing facilities, now in the making, are in full production. He spoke in Brussels at an […] Continue reading -> BioNTech To Ship Modular mRNA Vaccine Facilities in Containers to African Countries to Jump-start Production 16/02/2022 Elaine Ruth Fletcher The German-based BioNTech, which co-developed with Pfizer an mRNA COVID vaccine, said on Wednesday that it will set up modular “turnkey” mRNA vaccine facilities to produce the vaccine in Rwanda and Senegal in 2022 – with a fill-and-finish collaboration in Ghana as well. South Africa, which is the new hub for the WHO-supported mRNA vaccine […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
WTO Chief Hopes for “Workable Compromise” on TRIPS Waiver by June; US Signs Deal to Share COVID Vaccine Know-How with WHO 12/05/2022 Raisa Santos & Elaine Ruth Fletcher The United States National Institute of Health (NIH) has finalized an agreement with WHO’s COVID-19 patent sharing facility (C-TAP) to share the patent rights on 11 government-funded coronavirus medicine and vaccine technologies – in what is perhaps the most significant agreement to date with WHO to share closely-guarded pharma know-how. The announcement was made today […] Continue reading -> Moderna Seeks Dismissal in US Court of COVID-19 Vaccine Patent Infringement Lawsuit By Arbutus, Genevant 11/05/2022 Aishwarya Tendolkar Moderna has filed a brief in the United States District Court for the District of Delaware seeking the dismissal of a patent infringement lawsuit that pertains to the production and sale of its COVID-19 mRNA vaccine Spikevax. The lawsuit against the U.S-based pharmaceutical giant was filed by Arbutus Biopharma Corporation and Genevant Sciences, which had […] Continue reading -> After Months of Deadlock, WTO’s TRIPS Council Will Finally Discuss Intellectual Property Waiver Compromise 03/05/2022 Kerry Cullinan In a significant breakthrough, the World Trade Organization’s (WTO) TRIPS Council on Friday will finally discuss a compromise proposal on a waiver of intellectual property (IP) rights on COVID-19 vaccines – almost 18 months after it was first proposed by India and South Africa. Members attending an informal meeting of the TRIPS Council on Tuesday […] Continue reading -> Data-Sharing in the Time of COVID – Could Researchers Agree to Use a Common Clinical Trial ‘Repository’? 15/04/2022 Elaine Ruth Fletcher Nathalie Strub-Wourgaft, a senior scientist at the Drugs for Neglected Disease Initiative (DNDi) has a vision that could be critical to halting the next pandemic – but is esoteric, difficult to organize and even more challenging to build the trust and buy-in needed to make it really work. The vision is of a common clinical-trial […] Continue reading -> WTO IP Waiver ‘Compromise’ on COVID-19 Vaccines ‘Deeply Concerning’: Civil Society to European Leaders 30/03/2022 Aishwarya Tendolkar A compromise proposal on a World Trade Organisation’s (WTO) waiver on intellectual property for the production of COVID-19 vaccines is ‘problematic’, ‘largely insufficient’, and WTO members should not be politically pressured into adopting the text, several dozen civil society organisations said in an open letter published today. The letter, addressed to European Commissioners, European members […] Continue reading -> WTO Head Welcomes Compromise on IP Waiver for COVID Vaccines – But Activists and Pharma Express Dismay 16/03/2022 Kerry Cullinan The World Trade Organization’s (WTO) Director-Genera, Dr Ngozi Okonjo-Iweala has “warmly welcomed” the breakthrough reached this week over a waiver on intellectual property for the production of COVID-19 vaccines. “This is a major step forward and this compromise is the result of many long and difficult hours of negotiations. But we are not there yet. […] Continue reading -> South African President Lays Down Gauntlet to Europe: Approve IP Waiver And Procure Vaccines from African Manufacturers 18/02/2022 Elaine Ruth Fletcher South African President Cyril Ramaphosa Friday called on Gavi, The Vaccine Alliance, and COVAX, the global COVID vaccine consortium to begin procuring African-made versions of vaccines for COVID and other diseases, as soon as a network of new African manufacturing facilities, now in the making, are in full production. He spoke in Brussels at an […] Continue reading -> BioNTech To Ship Modular mRNA Vaccine Facilities in Containers to African Countries to Jump-start Production 16/02/2022 Elaine Ruth Fletcher The German-based BioNTech, which co-developed with Pfizer an mRNA COVID vaccine, said on Wednesday that it will set up modular “turnkey” mRNA vaccine facilities to produce the vaccine in Rwanda and Senegal in 2022 – with a fill-and-finish collaboration in Ghana as well. South Africa, which is the new hub for the WHO-supported mRNA vaccine […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Moderna Seeks Dismissal in US Court of COVID-19 Vaccine Patent Infringement Lawsuit By Arbutus, Genevant 11/05/2022 Aishwarya Tendolkar Moderna has filed a brief in the United States District Court for the District of Delaware seeking the dismissal of a patent infringement lawsuit that pertains to the production and sale of its COVID-19 mRNA vaccine Spikevax. The lawsuit against the U.S-based pharmaceutical giant was filed by Arbutus Biopharma Corporation and Genevant Sciences, which had […] Continue reading -> After Months of Deadlock, WTO’s TRIPS Council Will Finally Discuss Intellectual Property Waiver Compromise 03/05/2022 Kerry Cullinan In a significant breakthrough, the World Trade Organization’s (WTO) TRIPS Council on Friday will finally discuss a compromise proposal on a waiver of intellectual property (IP) rights on COVID-19 vaccines – almost 18 months after it was first proposed by India and South Africa. Members attending an informal meeting of the TRIPS Council on Tuesday […] Continue reading -> Data-Sharing in the Time of COVID – Could Researchers Agree to Use a Common Clinical Trial ‘Repository’? 15/04/2022 Elaine Ruth Fletcher Nathalie Strub-Wourgaft, a senior scientist at the Drugs for Neglected Disease Initiative (DNDi) has a vision that could be critical to halting the next pandemic – but is esoteric, difficult to organize and even more challenging to build the trust and buy-in needed to make it really work. The vision is of a common clinical-trial […] Continue reading -> WTO IP Waiver ‘Compromise’ on COVID-19 Vaccines ‘Deeply Concerning’: Civil Society to European Leaders 30/03/2022 Aishwarya Tendolkar A compromise proposal on a World Trade Organisation’s (WTO) waiver on intellectual property for the production of COVID-19 vaccines is ‘problematic’, ‘largely insufficient’, and WTO members should not be politically pressured into adopting the text, several dozen civil society organisations said in an open letter published today. The letter, addressed to European Commissioners, European members […] Continue reading -> WTO Head Welcomes Compromise on IP Waiver for COVID Vaccines – But Activists and Pharma Express Dismay 16/03/2022 Kerry Cullinan The World Trade Organization’s (WTO) Director-Genera, Dr Ngozi Okonjo-Iweala has “warmly welcomed” the breakthrough reached this week over a waiver on intellectual property for the production of COVID-19 vaccines. “This is a major step forward and this compromise is the result of many long and difficult hours of negotiations. But we are not there yet. […] Continue reading -> South African President Lays Down Gauntlet to Europe: Approve IP Waiver And Procure Vaccines from African Manufacturers 18/02/2022 Elaine Ruth Fletcher South African President Cyril Ramaphosa Friday called on Gavi, The Vaccine Alliance, and COVAX, the global COVID vaccine consortium to begin procuring African-made versions of vaccines for COVID and other diseases, as soon as a network of new African manufacturing facilities, now in the making, are in full production. He spoke in Brussels at an […] Continue reading -> BioNTech To Ship Modular mRNA Vaccine Facilities in Containers to African Countries to Jump-start Production 16/02/2022 Elaine Ruth Fletcher The German-based BioNTech, which co-developed with Pfizer an mRNA COVID vaccine, said on Wednesday that it will set up modular “turnkey” mRNA vaccine facilities to produce the vaccine in Rwanda and Senegal in 2022 – with a fill-and-finish collaboration in Ghana as well. South Africa, which is the new hub for the WHO-supported mRNA vaccine […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
After Months of Deadlock, WTO’s TRIPS Council Will Finally Discuss Intellectual Property Waiver Compromise 03/05/2022 Kerry Cullinan In a significant breakthrough, the World Trade Organization’s (WTO) TRIPS Council on Friday will finally discuss a compromise proposal on a waiver of intellectual property (IP) rights on COVID-19 vaccines – almost 18 months after it was first proposed by India and South Africa. Members attending an informal meeting of the TRIPS Council on Tuesday […] Continue reading -> Data-Sharing in the Time of COVID – Could Researchers Agree to Use a Common Clinical Trial ‘Repository’? 15/04/2022 Elaine Ruth Fletcher Nathalie Strub-Wourgaft, a senior scientist at the Drugs for Neglected Disease Initiative (DNDi) has a vision that could be critical to halting the next pandemic – but is esoteric, difficult to organize and even more challenging to build the trust and buy-in needed to make it really work. The vision is of a common clinical-trial […] Continue reading -> WTO IP Waiver ‘Compromise’ on COVID-19 Vaccines ‘Deeply Concerning’: Civil Society to European Leaders 30/03/2022 Aishwarya Tendolkar A compromise proposal on a World Trade Organisation’s (WTO) waiver on intellectual property for the production of COVID-19 vaccines is ‘problematic’, ‘largely insufficient’, and WTO members should not be politically pressured into adopting the text, several dozen civil society organisations said in an open letter published today. The letter, addressed to European Commissioners, European members […] Continue reading -> WTO Head Welcomes Compromise on IP Waiver for COVID Vaccines – But Activists and Pharma Express Dismay 16/03/2022 Kerry Cullinan The World Trade Organization’s (WTO) Director-Genera, Dr Ngozi Okonjo-Iweala has “warmly welcomed” the breakthrough reached this week over a waiver on intellectual property for the production of COVID-19 vaccines. “This is a major step forward and this compromise is the result of many long and difficult hours of negotiations. But we are not there yet. […] Continue reading -> South African President Lays Down Gauntlet to Europe: Approve IP Waiver And Procure Vaccines from African Manufacturers 18/02/2022 Elaine Ruth Fletcher South African President Cyril Ramaphosa Friday called on Gavi, The Vaccine Alliance, and COVAX, the global COVID vaccine consortium to begin procuring African-made versions of vaccines for COVID and other diseases, as soon as a network of new African manufacturing facilities, now in the making, are in full production. He spoke in Brussels at an […] Continue reading -> BioNTech To Ship Modular mRNA Vaccine Facilities in Containers to African Countries to Jump-start Production 16/02/2022 Elaine Ruth Fletcher The German-based BioNTech, which co-developed with Pfizer an mRNA COVID vaccine, said on Wednesday that it will set up modular “turnkey” mRNA vaccine facilities to produce the vaccine in Rwanda and Senegal in 2022 – with a fill-and-finish collaboration in Ghana as well. South Africa, which is the new hub for the WHO-supported mRNA vaccine […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Data-Sharing in the Time of COVID – Could Researchers Agree to Use a Common Clinical Trial ‘Repository’? 15/04/2022 Elaine Ruth Fletcher Nathalie Strub-Wourgaft, a senior scientist at the Drugs for Neglected Disease Initiative (DNDi) has a vision that could be critical to halting the next pandemic – but is esoteric, difficult to organize and even more challenging to build the trust and buy-in needed to make it really work. The vision is of a common clinical-trial […] Continue reading -> WTO IP Waiver ‘Compromise’ on COVID-19 Vaccines ‘Deeply Concerning’: Civil Society to European Leaders 30/03/2022 Aishwarya Tendolkar A compromise proposal on a World Trade Organisation’s (WTO) waiver on intellectual property for the production of COVID-19 vaccines is ‘problematic’, ‘largely insufficient’, and WTO members should not be politically pressured into adopting the text, several dozen civil society organisations said in an open letter published today. The letter, addressed to European Commissioners, European members […] Continue reading -> WTO Head Welcomes Compromise on IP Waiver for COVID Vaccines – But Activists and Pharma Express Dismay 16/03/2022 Kerry Cullinan The World Trade Organization’s (WTO) Director-Genera, Dr Ngozi Okonjo-Iweala has “warmly welcomed” the breakthrough reached this week over a waiver on intellectual property for the production of COVID-19 vaccines. “This is a major step forward and this compromise is the result of many long and difficult hours of negotiations. But we are not there yet. […] Continue reading -> South African President Lays Down Gauntlet to Europe: Approve IP Waiver And Procure Vaccines from African Manufacturers 18/02/2022 Elaine Ruth Fletcher South African President Cyril Ramaphosa Friday called on Gavi, The Vaccine Alliance, and COVAX, the global COVID vaccine consortium to begin procuring African-made versions of vaccines for COVID and other diseases, as soon as a network of new African manufacturing facilities, now in the making, are in full production. He spoke in Brussels at an […] Continue reading -> BioNTech To Ship Modular mRNA Vaccine Facilities in Containers to African Countries to Jump-start Production 16/02/2022 Elaine Ruth Fletcher The German-based BioNTech, which co-developed with Pfizer an mRNA COVID vaccine, said on Wednesday that it will set up modular “turnkey” mRNA vaccine facilities to produce the vaccine in Rwanda and Senegal in 2022 – with a fill-and-finish collaboration in Ghana as well. South Africa, which is the new hub for the WHO-supported mRNA vaccine […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
WTO IP Waiver ‘Compromise’ on COVID-19 Vaccines ‘Deeply Concerning’: Civil Society to European Leaders 30/03/2022 Aishwarya Tendolkar A compromise proposal on a World Trade Organisation’s (WTO) waiver on intellectual property for the production of COVID-19 vaccines is ‘problematic’, ‘largely insufficient’, and WTO members should not be politically pressured into adopting the text, several dozen civil society organisations said in an open letter published today. The letter, addressed to European Commissioners, European members […] Continue reading -> WTO Head Welcomes Compromise on IP Waiver for COVID Vaccines – But Activists and Pharma Express Dismay 16/03/2022 Kerry Cullinan The World Trade Organization’s (WTO) Director-Genera, Dr Ngozi Okonjo-Iweala has “warmly welcomed” the breakthrough reached this week over a waiver on intellectual property for the production of COVID-19 vaccines. “This is a major step forward and this compromise is the result of many long and difficult hours of negotiations. But we are not there yet. […] Continue reading -> South African President Lays Down Gauntlet to Europe: Approve IP Waiver And Procure Vaccines from African Manufacturers 18/02/2022 Elaine Ruth Fletcher South African President Cyril Ramaphosa Friday called on Gavi, The Vaccine Alliance, and COVAX, the global COVID vaccine consortium to begin procuring African-made versions of vaccines for COVID and other diseases, as soon as a network of new African manufacturing facilities, now in the making, are in full production. He spoke in Brussels at an […] Continue reading -> BioNTech To Ship Modular mRNA Vaccine Facilities in Containers to African Countries to Jump-start Production 16/02/2022 Elaine Ruth Fletcher The German-based BioNTech, which co-developed with Pfizer an mRNA COVID vaccine, said on Wednesday that it will set up modular “turnkey” mRNA vaccine facilities to produce the vaccine in Rwanda and Senegal in 2022 – with a fill-and-finish collaboration in Ghana as well. South Africa, which is the new hub for the WHO-supported mRNA vaccine […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
WTO Head Welcomes Compromise on IP Waiver for COVID Vaccines – But Activists and Pharma Express Dismay 16/03/2022 Kerry Cullinan The World Trade Organization’s (WTO) Director-Genera, Dr Ngozi Okonjo-Iweala has “warmly welcomed” the breakthrough reached this week over a waiver on intellectual property for the production of COVID-19 vaccines. “This is a major step forward and this compromise is the result of many long and difficult hours of negotiations. But we are not there yet. […] Continue reading -> South African President Lays Down Gauntlet to Europe: Approve IP Waiver And Procure Vaccines from African Manufacturers 18/02/2022 Elaine Ruth Fletcher South African President Cyril Ramaphosa Friday called on Gavi, The Vaccine Alliance, and COVAX, the global COVID vaccine consortium to begin procuring African-made versions of vaccines for COVID and other diseases, as soon as a network of new African manufacturing facilities, now in the making, are in full production. He spoke in Brussels at an […] Continue reading -> BioNTech To Ship Modular mRNA Vaccine Facilities in Containers to African Countries to Jump-start Production 16/02/2022 Elaine Ruth Fletcher The German-based BioNTech, which co-developed with Pfizer an mRNA COVID vaccine, said on Wednesday that it will set up modular “turnkey” mRNA vaccine facilities to produce the vaccine in Rwanda and Senegal in 2022 – with a fill-and-finish collaboration in Ghana as well. South Africa, which is the new hub for the WHO-supported mRNA vaccine […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
South African President Lays Down Gauntlet to Europe: Approve IP Waiver And Procure Vaccines from African Manufacturers 18/02/2022 Elaine Ruth Fletcher South African President Cyril Ramaphosa Friday called on Gavi, The Vaccine Alliance, and COVAX, the global COVID vaccine consortium to begin procuring African-made versions of vaccines for COVID and other diseases, as soon as a network of new African manufacturing facilities, now in the making, are in full production. He spoke in Brussels at an […] Continue reading -> BioNTech To Ship Modular mRNA Vaccine Facilities in Containers to African Countries to Jump-start Production 16/02/2022 Elaine Ruth Fletcher The German-based BioNTech, which co-developed with Pfizer an mRNA COVID vaccine, said on Wednesday that it will set up modular “turnkey” mRNA vaccine facilities to produce the vaccine in Rwanda and Senegal in 2022 – with a fill-and-finish collaboration in Ghana as well. South Africa, which is the new hub for the WHO-supported mRNA vaccine […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
BioNTech To Ship Modular mRNA Vaccine Facilities in Containers to African Countries to Jump-start Production 16/02/2022 Elaine Ruth Fletcher The German-based BioNTech, which co-developed with Pfizer an mRNA COVID vaccine, said on Wednesday that it will set up modular “turnkey” mRNA vaccine facilities to produce the vaccine in Rwanda and Senegal in 2022 – with a fill-and-finish collaboration in Ghana as well. South Africa, which is the new hub for the WHO-supported mRNA vaccine […] Continue reading -> Posts navigation Older postsNewer posts